Patent ID: 8741953

Claim:
A topical gel formulation for the treatment of chronic wounds comprising: a. Esmolol hydrochloride at about 10% to about 20%; b. Poloxamer 338 at about 25% to about 35%; c. 50% benzalkonium chloride at about 0.2% to about 0.3%; d. sodium acetate trihydrate at about 0.2% to about 0.3%; e. glacial acetic acid at about 0.03% to about 0.07%; f. concentrated hydrochloric acid at about 0.02% to about 0.08%; g. purified water at about 40% to about 60%; and wherein the formulation has pH between 4.0 to 6.0 and having thermoreversible property and packaged in a suitable container.